Multiply relapsing hairy cell leukemia responsive to repeated courses of rituximab: A case report |
| |
| Authors: | Rena Buckstein Harshna Patel Alden Chesney Marciano Reis Kevin Imrie |
| |
| Affiliation: | Toronto Sunnybrook Regional Cancer Centre, Sunnybrook and Women's College Health Sciences Centre, Toronto, Ont., Canada, M4N 3M5 |
| |
| Abstract: | While cladribine is a highly effective therapy for patients with symptomatic hairy cell leukemia (HCL), up to 37% of patients ultimately relapse and incompletely responding patients relapse more frequently. Rituximab is a monoclonal antibody against CD20 that has been shown to be effective in patients with relapsed HCL. We present an unusual case of successful multiple re-treatments with rituximab in a patient with heavily pre-treated HCL and briefly review the relevant literature. |
| |
| Keywords: | HAIRY CELL LEUKEMIA RITUXIMAB CLADRIBINE CASE REPORT |
|
